文献速递生殖医学

APHRODITE标准:针对特发性睾丸功能改变所致性腺功能减退和/或不育男性患者的分类

APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function.
PubMed 文献 · Reprod Biomed Online · 2023-10-29

APHRODITE标准由男科、生殖泌尿外科和妇科专家通过迭代共识制定,基于临床描述和常规实验室检查,将不育男性分为五组:低促性腺激素性性腺功能减退(获得性和先天性)、特发性男性不育伴精液参数降低且FSH和总睾酮正常、性腺功能减退伴精液参数降低且FSH正常和总睾酮降低、精液参数降低伴FSH升高和总睾酮降低或正常、以及不明原因夫妻不育背景下的不明原因男性不育。该标准独立于病因和生精改变,旨在促进沟通并改善激素治疗后的生殖结局,提议作为未来激素治疗试验的基础。

要点

  • APHRODITE标准将不育男性分为五组,基于精液分析和激素检测。
  • 分组包括低促性腺激素性性腺功能减退、特发性不育伴正常FSH和睾酮等。
  • 该标准旨在标准化患者分层,促进临床沟通和激素治疗试验设计。

核心结论

  • APHRODITE标准提供了一种独立于病因和/或生精改变的新型标准化患者分层系统,促进临床医生、研究人员和患者之间的沟通,以改善激素治疗后的生殖结局,并提议作为未来男性不育激素治疗试验的基础。

研究设计与样本

  • 由男科医生、生殖泌尿外科医生和妇科医生合作,通过基于临床患者描述和常规实验室检查(包括精液分析和激素检测)结果的迭代共识过程制定。

主要发现

  • delineated five patient groups: (1) 低促性腺激素性性腺功能减退(获得性和先天性);(2) 特发性男性不育伴精液分析参数降低、血清FSH正常和血清总睾酮浓度正常;(3) 性腺功能减退状态伴精液分析参数降低、FSH正常和总睾酮浓度降低;(4) 精液分析参数降低、FSH浓度升高和总睾酮浓度降低或正常;(5) 不明原因夫妻不育背景下的不明原因男性不育。

关键数值与推荐

  • 根据APHRODITE标准,患者被分为五组:1. 低促性腺激素性性腺功能减退(获得性和先天性);2. 特发性男性不育伴精液分析参数降低、血清FSH正常和血清总睾酮浓度正常;3. 性腺功能减退状态伴精液分析参数降低、FSH正常和总睾酮浓度降低;4. 精液分析参数降低、FSH浓度升高和总睾酮浓度降低或正常;5. 不明原因夫妻不育背景下的不明原因男性不育。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Can a novel classification system of the infertile male - 'APHRODITE' (Addressing male Patients with Hypogonadism and/or infeRtility Owing to altereD, Idiopathic TEsticular function) - stratify different subgroups of male infertility to help scientists to design clinical trials on the hormonal treatment of male infertility, and clinicians to counsel and treat the endocrinological imbalances in men and, ultimately, increase the chances of natural and assisted conception? DESIGN: A collaboration between andrologists, reproductive urologists and gynaecologists, with specialization in reproductive medicine and expertise in male infertility, led to the development of the APHRODITE criteria through an iterative consensus process based on clinical patient descriptions and the results of routine laboratory tests, including semen analysis and hormonal testing. RESULTS: Five patient groups were delineated according to the APHRODITE criteria; (1) Hypogonadotrophic hypogonadism (acquired and congenital); (2) Idiopathic male infertility with lowered semen analysis parameters, normal serum FSH and normal serum total testosterone concentrations; (3) A hypogonadal state with lowered semen analysis parameters, normal FSH and reduced total testosterone concentrations; (4) Lowered semen analysis parameters, elevated FSH concentrations and reduced or normal total testosterone concentrations; and (5) Unexplained male infertility in the context of unexplained couple infertility. CONCLUSION: The APHRODITE criteria offer a novel and standardized patient stratification system for male infertility independent of aetiology and/or altered spermatogenesis, facilitating communication among clinicians, researchers and patients to improve reproductive outcomes following hormonal therapy. APHRODITE is proposed as a basis for future trials of the hormonal treatment of male infertility.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Esteves SC, Humaidan P, Ubaldi FM, et al. APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function. Reprod Biomed Online. 2023. PMID: 38367592. doi:10.1016/j.rbmo.2023.103647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。